DOWNLOAD CATALOGUE

Our Company
- Our Corporate Structure
Our Science
- Innovative Generics (Gx+)
  - Our Innovation Strategy
  - Our Innovative Projects
- Pharma Manufacturing & QC
Our Products & Services
- Our Products in Greece
- Our Diagnostics

Your Career
Ελληνικά

0

$0.00

✕

MARKET AVAILABILITY

Ezetimibe/Simvastatin

Home
Προϊόν ACTIVE SUBSTANCE
Ezetimibe/Simvastatin

fixed-dose combination

THERAPEUTIC AREA -

Allergy
Anesthesiology
Cardiology / Diagnostic imaging
Cardiovascular
Cardiovascular / Antithrombotic therapy
Cardiovascular / Cardiology
Cardiovascular / Dyslipidemia
Cardiovascular / Hypertension
Endocrinology
Endocrinology / Bone metabolism
Infectious diseases
Iron deficiency
Musculoskeletal disorders
Nephrology
Neurology
Neurology / Alzheimer's disease
Neurology / Epilepsy
Neurology / Peripheral neuropathy
Obstetrics
Oncology
Oncology / Endocrinology
Oncology / Hematology
Oncology / Urology
Psychiatry
Psychiatry / Neurology
Radiology / Diagnostic imaging
Radiology / MRI contrast enhancement

PHARMACOLOGICAL CLASS +

Acetylcholinesterase inhibitor
Alzheimer’s disease
Anticoagulant
Antidepressant
Antidote / Biochemical modulator
Antiepileptic
Antihyperlipidemic
Antihypertensive
Antimigraine
Antineoplastic
Antiplatelet
Antipsychotic
Aromatase inhibitor
Biological lubricant
Bisphosphonate
Calcimimetic
Cholinesterase inhibitor
Coronary vasodilator
Diagnostic
DPP‑4 inhibitor
Echinocandin antifungal
Folate analogue
GnRH agonist
Immunotherapy
Iron supplement
Leukotriene receptor antagonist
Monoamine oxidase type B (MAO‑B) inhibitor
Oral hypoglycemic
Pyrimidine synthesis inhibitor
Selective relaxant binding agent (SRBA)
Skeletal muscle relaxant
Vitamin B complex
Vitamin D

BUSINESS UNIT +

CNS
Contrast Media Agents
Oncology
Primary Care
Radiopharmaceutical
Teriflunomide

ACTIVE SUBSTANCE +

Abiraterone
Agomelatine
Aledronate
Amlodipine/Valsartan
Aripiprazole
Atorvastatin
Bacillus Calmette-Guerin
Baclofen
Brivaracetam
Calcium Folinate
Capecitabine
Cholecalciferol
Cinacalcet
Clopidogrel
Donepezil
Duloxetine
Everolimus
Exemestane
Ezetimibe/Atorvastatin
Ezetimibe/Simvastatin
Ferrous Gluconate
Folinic Acid
Gadobutrol
Gadoteric Acid
Hyaluronate Sodium
Iodixanol
Iohexol
Letrozole
Leuprorelin
Levetiracetam
Losartan/Hydrochlorothiazide
Lurasidone
Memantine
Micafungin
Montelukast
Nebivolol
Olanzapine
Paliperidone
Perflutren
Pitavastatin
Pravastatin/Fenofibrate
Quetiapine
Rasagiline
Regadenoson
Rivaroxaban
Rivastigmine
Rosa canina
Rosuvastatin
Sitagliptin
Sitagliptin/Metformin
Sugammadex
Sumatriptan
Teriflunomide
Thiamine/Pyridoxine/Cyanocobalamin
Ticagrelor
Topiramate
Valsartan
Valsartan/Hydrochlorothiazide
Venlafaxine
Vinorelbine

PRESCRIPTION REQUIREMENT +

OTC (over-the-counter)
Rx (prescription required)

Vasitimb®

PHARMAZAC

THERAPEUTIC AREA -

Allergy
Anesthesiology
Cardiology / Diagnostic imaging
Cardiovascular
Cardiovascular / Antithrombotic therapy
Cardiovascular / Cardiology
Cardiovascular / Dyslipidemia
Cardiovascular / Hypertension
Endocrinology
Endocrinology / Bone metabolism
Infectious diseases
Iron deficiency
Musculoskeletal disorders
Nephrology
Neurology
Neurology / Alzheimer's disease
Neurology / Epilepsy
Neurology / Peripheral neuropathy
Obstetrics
Oncology
Oncology / Endocrinology
Oncology / Hematology
Oncology / Urology
Psychiatry
Psychiatry / Neurology
Radiology / Diagnostic imaging
Radiology / MRI contrast enhancement

PHARMACOLOGICAL CLASS +

Acetylcholinesterase inhibitor
Alzheimer’s disease
Anticoagulant
Antidepressant
Antidote / Biochemical modulator
Antiepileptic
Antihyperlipidemic
Antihypertensive
Antimigraine
Antineoplastic
Antiplatelet
Antipsychotic
Aromatase inhibitor
Biological lubricant
Bisphosphonate
Calcimimetic
Cholinesterase inhibitor
Coronary vasodilator
Diagnostic
DPP‑4 inhibitor
Echinocandin antifungal
Folate analogue
GnRH agonist
Immunotherapy
Iron supplement
Leukotriene receptor antagonist
Monoamine oxidase type B (MAO‑B) inhibitor
Oral hypoglycemic
Pyrimidine synthesis inhibitor
Selective relaxant binding agent (SRBA)
Skeletal muscle relaxant
Vitamin B complex
Vitamin D

BUSINESS UNIT +

CNS
Contrast Media Agents
Oncology
Primary Care
Radiopharmaceutical
Teriflunomide

ACTIVE SUBSTANCE +

Abiraterone
Agomelatine
Aledronate
Amlodipine/Valsartan
Aripiprazole
Atorvastatin
Bacillus Calmette-Guerin
Baclofen
Brivaracetam
Calcium Folinate
Capecitabine
Cholecalciferol
Cinacalcet
Clopidogrel
Donepezil
Duloxetine
Everolimus
Exemestane
Ezetimibe/Atorvastatin
Ezetimibe/Simvastatin
Ferrous Gluconate
Folinic Acid
Gadobutrol
Gadoteric Acid
Hyaluronate Sodium
Iodixanol
Iohexol
Letrozole
Leuprorelin
Levetiracetam
Losartan/Hydrochlorothiazide
Lurasidone
Memantine
Micafungin
Montelukast
Nebivolol
Olanzapine
Paliperidone
Perflutren
Pitavastatin
Pravastatin/Fenofibrate
Quetiapine
Rasagiline
Regadenoson
Rivaroxaban
Rivastigmine
Rosa canina
Rosuvastatin
Sitagliptin
Sitagliptin/Metformin
Sugammadex
Sumatriptan
Teriflunomide
Thiamine/Pyridoxine/Cyanocobalamin
Ticagrelor
Topiramate
Valsartan
Valsartan/Hydrochlorothiazide
Venlafaxine
Vinorelbine

PRESCRIPTION REQUIREMENT +

OTC (over-the-counter)
Rx (prescription required)

Headquarters, Pharmaceutical Manufacturing Site & R&D Laboratory

1, Anastasiou Zaroliagki & 6, Dimitriou Lamprou Str.
GR-19001 Keratea – Attica
Greece
Tel. +30 210 3418889-97
Fax +30 210 8661262

Radiopharmaceutical Manufacturing Site

Naousis 31
Athens 104 47,
Votanikos Greece
Tel. +30 210 3418889-97
Fax +30 210 8661262

P. Patron Germanou 27
Thessaloniki 546 42, Greece
Tel. +30 2310 933534
Fax +30 2310 933524

Report of Adverse Events

For any adverse events report contact the Pharmaco-vigilance or Medical information department:
Τel : +30 210 3259365 (24/7 line ),
Fax: +30 210 3259368,
email: pv@creativephs.com